Showing results (2431-2440 of 2,553) with videos related to

Sort By:
Pageof 256
Neuro-Oncology Advances|December 23, 2020
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsJessica D Schulte, Robin A Buerki, Sarah Lapointe, et al.
The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.
JACC. Clinical Electrophysiology|February 8, 2023
Conduction System Pacing Versus Conventional Cardiac Resynchronization Therapy in Congenital Heart DiseaseJeremy P Moore, Natasja M S de Groot, Matthew O'Connor, et al.
Neuro-Oncology|April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experienceEudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
The Lancet. Oncology|October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translationAnahita Fathi Kazerooni, Ariana M Familiar, Mariam Aboian, et al.
The Lancet. Oncology|January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working groupD Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titerP L Sheridan, M Bodner, A Lynn, et al.
Neuro-Oncology|March 19, 2009
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 26, 2018
Effect of Achieving Minimal Disease Activity on the Progression of Subclinical Atherosclerosis and Arterial Stiffness: A Prospective Cohort Study in Psoriatic ArthritisIsaac T Cheng, Qing Shang, Edmund K Li, et al.
Pageof 256